Chinese Embassy expresses appreciation for medicine’s FDA approval
MANILA – The Chinese Embassy in Manila expressed its appreciation to the Philippines’ Food and Drug Administration’s (FDA) approval of Chinese medicine known as Lian Hua Qing Wen made by one of Chinese’s famous Traditional Chinese Medicine (TCM) manufacturers, Shijiazhuang Yiling Pharmaceutical Co. Ltd., formally registered as TCM in the country.
The Embassy’s spokesperson said the approval “marks an important progress in the entry of TCM products in the Philippine market.”
Lianhua Qingwen Capsule is an approved COVID-19 treatment for mild and moderate cases in China. The same medicine has been approved in Hong Kong and Macao, SAR of China, Brazil, Indonesia, Canada, Mozambique, Romania, Thailand, Ecuador, Singapore and Lao PDR.
“It is our sincere hope that its entrance into the Philippine market will contribute to the fight against the spread of COVID-19 in the country and help the patients with mild and moderate symptoms recover,” the Embassy statement said.
The Embassy has advised consumers to purchase and consume authentic TCM produced by qualified pharmaceutical manufacturers and hopes TCM will play a bigger role to support the Philippines’ efforts to fight COVID-19. (Melo M. Acuña)
Lianhua Qingwen, considered part of Traditional Chinese Medicine, approved by the Philippines' Food and Drug Administration. (Chinese Embassy photos)